Human Ron-related gene variant associated with cancers
AssigneeVisgeneer, Inc.
InventorKen-Shwo Dai
Life of this patent
Estimating the term…
Abstract
The invention relates to the nucleic acid and polypeptide sequences of three novel human Ron-related gene variants (Ron-V1, Ron-V2, and Ron-V3). The invention also provides a process for producing the polypeptides of the variants, as well as uses for the nucleic acid, polypeptide and antibodies to same in diagnosing human breast carcinoma, breast adenocarcinoma, cervix epidermoid carcinoma, cervix epitheloid carcinoma, colon adenocarcinoma, urinary bladder carcinoma, prostate carcinoma, esophagus epidermoid carcinoma and esophagus carcinoma.
Claims6
An isolated nucleic acid encoding the amino acid sequence of SEQ ID NO:
- 4.
An isolated nucleic acid consisting of 30 consecutive nucleotides of SEQ ID NO:
- 3 and that overlaps a dinucleotide selected from the group consisting of nucleotides 2837-2838 of SEQ ID NO:
- 3, nucleotides 3583-3584 of SEQ ID NO:
- 3, and nucleotides 3725-3726 of SEQ ID NO:
- 3.
Dependencies are inferred from the claim text.